Registration Dossier
Registration Dossier
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 271-233-5 | CAS number: 68526-84-1
Endpoint summary
Administrative data
Description of key information
Key value for chemical safety assessment
Additional information
Acute toxicity studies have been undertaken on Isononanol by all three major routes of human exposure. Although none of the studies were conducted to GLP, they were reasonably well documented and generally conformed to recognised standards for acute toxicity testing.
Oral
In the key study, single administrations of Isononanol were given via oral gavage to 5 male rats at doses of 34.6, 120, 417, 1450, 5000, and 10000 mg/kg to assess the acute oral toxicity. All animals died within 24 hours post exposure in the 10000 mg/kg dose group. Three of 5 animals in the 5000 mg/kg dose group died within 48 hours of exposure. Based on the results of this study, the estimated LD50 is 2979 mg/kg.
Inhalation
In the key study, Isononanol was administered via a vapor inhalation, generated by positive pressure spray, to 10 each of mice, rats, and guinea pigs at the nominal concentration of 21.7 mg/l for 6 hours. During the exposure, signs of irritation observed included transient restlessness followed by extreme inactivity, eye irritation, and shallow respiration. Swelling of the rims of the eyes, hyperemia of the ears, and a red-brown encrustation around the nose were noted when the animals were returned to group housing. In addition, three rats and two mice were in a state of collapse. Two rats and one mouse succumbed within 14 hours of the termination of the study. Gross necropsy findings included discolored lungs and livers in the animals. At the end of the study, the LC50 was >21.7 mg/l for each species.
Dermal
Isononanol was administered via an occluded dermal patch to 4 male and female rabbits at doses of 50, 200, 794, and 3160 mg/kg for 24 hours to assess acute dermal toxicity. Clinical observations were made once daily for 14 days following the 24 exposure. All animals survived until study termination. The only adverse clinical signs noted were slight irritation 24 hours after exposure. This finding was resolved by day 6. Based on the results in this study, the LD50 is greater than 3160 mg/kg.
Justification for classification or non-classification
No classification for acute toxicity is indicated according to the general classification and labeling requirements for dangerous substances and preparations (Directive 67-548-EEC) or the classification, labeling and packaging (CLP) regulation (EC) No 1272/2008.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
